2-((1-(2-(4-Fluorophenyl)-2-Oxoethyl)Piperidin-4-Yl)Methyl)Isoindolin-1-One 2-[[1-[2-(4-氟苯基)-2-氧代乙基]-4-哌啶基]甲基]-2,3-二氢-1H-异吲哚-1-酮
CAS 359625-79-9 MFCD59625799
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [1]. Davidson M, et al. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. Am J Psychiatry. 2017 Jul 28:appiajp201717010122.